BioCaptiva

Hologenomix

Hologenomix develops an extraction platform for isolating cell-free nucleic acids from biofluids to provide liquid biopsy and molecular diagnostic services to research and healthcare institutions.

Smartcatch

This company develops microtechnology devices for isolating circulating tumour cells from blood samples to assist researchers and clinicians in cancer diagnosis and monitoring.

Fyr Bio

This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.

Amplifyer Bio

This company develops humanised priming agents that increase circulating tumour DNA recovery to improve liquid biopsy sensitivity for cancer diagnostic providers.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

Avant Genomics

The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.